Evidence map›Paper›PMID 21507719›Full record

ArticleTrends in parasitology2011

How specific is Plasmodium falciparum adherence to chondroitin 4-sulfate?

Suchi Goel, D Channe Gowda

Abstract read
In one paragraph

Article in Trends in parasitology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Suchi GoelDepartment of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, USA.
D Channe Gowda
Pennsylvania State University · US

Funding

Innate Immune Responses to Malaria ParasitesR01AI041139 · NIAID · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI GOWDA, CHANNE D · 1998 to 2017
$5.8M
CYTOADHERENCE IN MATERNAL MALARIAR01AI045086 · NIAID · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI GOWDA, CHANNE D · 1999 to 2009
$2.2M
CYTOADHERENCE IN MATERNAL MALARIAR21AI045086 · NIAID · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI GOWDA, CHANNE D · 2004 to 2004
$296k
NIAID NIH HHS AI45086NIAID NIH HHS R01 AI041139NIAID NIH HHS R01 AI045086NIAID NIH HHS R21 AI045086
6 · The paper itself

Abstract

Plasmodium falciparum infection during pregnancy results in the sequestration of infected red blood cells (IRBCs) in the placenta, contributing to pregnancy associated malaria (PAM). IRBC adherence is mediated by the binding of a variant Plasmodium falciparum erythrocyte binding protein 1 named VAR2CSA to the low sulfated chondroitin 4-sulfate (C4S) proteoglycan (CSPG) present predominantly in the intervillous space of the placenta. IRBC binding is highly specific to the level and distribution of 4-sulfate groups in C4S. Given the strict specificity of IRBC-C4S interactions, it is better to use either placental CSPG or CSPGs bearing structurally similar C4S chains in defining VAR2CSA structural architecture that interact with C4S, evaluating VAR2CSA constructs for vaccine development or studying structure-based inhibitors as therapeutics for PAM.

Indexed as

AntigensAntigens, ProtozoanCell AdhesionChondroitin Sulfate Proteoglycan 4Chondroitin SulfatesErythrocytesFemaleHumansMalaria, FalciparumPlacentaPlasmodium falciparumPregnancyPregnancy Complications, ParasiticProtein BindingProteoglycansProtozoan ProteinsAntigensAntigens, ProtozoanChondroitin Sulfate Proteoglycan 4Chondroitin Sulfateserythrocyte membrane protein 1, Plasmodium falciparumProteoglycansProtozoan ProteinsVAR2CSA protein, Plasmodium falciparum

Identifiers

PMID21507719
PMCPMC3153608
OpenAlexW2073590883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.